| Net income | |
| Depreciation and amortization | |
| Accretion of discount and other amortization | -8.16M |
| Interest income in CDOs redirected for reinvestment or CDO bonds paydown | |
| Interest income on investments accrued to principal balance | -25.57M |
| Interest expense on debt accrued to principal balance | |
| Deferred interest received | |
| Non-cash directors' compensation | |
| Reversal of valuation allowance on loans | |
| Other-than-temporary impairment on securities | 110K |
| Impairment on real estate held for sale | |
| Gain on settlement of investments, net | |
| Unrealized loss on non-hedge derivatives and hedge ineffectiveness | 1.7M |
| Gain on extinguishment of debt | 607K |
| Restricted cash | -2.49M |
| Receivables and other assets | -4.31M |
| Due to affiliates | |
| Accrued expenses and other liabilities | |
| Net cash provided by (used in) operating activities | |
| Purchase of real estate securities | -1.62B |
| Proceeds from sale of real estate securities | |
| Acquisition of servicing rights | |
| Principal repayments on loans and securities other than third-party CDO | |
| Principal repayments on third-party CDO securities | |
| Repayments of principal from repurchased CDO debt | |
| Margin received on derivative instruments | |
| Payments on settlement of derivative instruments | |
| Distributions of capital from equity method investees | |
| Net cash provided by (used in) investing activities | -378.25M |
| Repurchases of CDO bonds payable | 0 |
| Issuance of other bonds payable | 1.67B |
| Repayments of other bonds payable | -1.16B |
| Borrowings under repurchase agreements | |
| Repayments of repurchase agreements | |
| Issuance of common stock | |
| Costs related to issuance of common stock | |
| Cash consideration paid in exchange for junior subordinated notes | |
| Cash consideration paid to redeem preferred stock | |
| Dividends paid | |
| Payment of deferred financing costs | -3.67M |
| Restricted cash returned from refinancing activities | |
| Net cash provided by (used in) financing activities | 481.59M |
| Net Increase (Decrease) in Cash and Cash Equivalents | 88.64M |
| Cash and Cash Equivalents, Beginning of Period | 45.65M |
| Cash and Cash Equivalents, End of Period | 134.29M |
| Cash paid during the period for interest expense | |
| Common stock dividends declared but not paid | 0 |
| Preferred stock dividends declared but not paid | 0 |
| Common stock issued to redeem preferred stock | |
| Face amount of CDO bonds issued in exchange for previously issued junior subordinated notes of $52,094 | |
| Securities purchased not yet settled | |